Standout Papers

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease 2013 2026 2017 2021 885
  1. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease (2013)
    Rachelle S. Doody, Rema Raman et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 25 from Science/Nature 104 standout
Sub-graph 1 of 19

Citing Papers

Applied body-fluid analysis by wearable devices
2024 StandoutNature
Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
16 intermediate papers

Works of Feng He being referenced

CCR2-engineered mesenchymal stromal cells accelerate diabetic wound healing by restoring immunological homeostasis
2021
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
2013 Standout

Author Peers

Author Last Decade Papers Cites
Feng He 294 195 136 711 552 53 2.0k
Frank Stam 224 313 133 1375 709 67 3.0k
Brian M. Gilfix 151 394 89 471 630 59 2.0k
Wen Li 98 127 104 877 630 72 2.1k
Omar Laterza 395 193 182 361 922 58 2.2k
Giuseppe Di Fede 113 407 80 679 734 92 2.7k
Jin Jun Luo 58 160 102 729 632 81 2.4k
Yasuko Takahashi 66 245 100 741 1137 57 2.2k
Jorge F. Giani 189 204 171 340 953 72 2.6k
Paola Nicoletti 32 211 364 608 898 51 3.0k
Edward L. Posvar 65 290 50 201 537 29 1.6k

All Works

Loading papers...

Rankless by CCL
2026